MediWound Ltd.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 30, 2026 · Filed Aug 13, 2026
Use the contents to explore the available documents and sections.
MDWD$14.25+6.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Adjusted EBITDA
Adjusted EBITDA
| Six months ended · Three months ended · Year Ended | |||||
|---|---|---|---|---|---|
| June 30, · June 30, · December 31, | |||||
| 2026 | 2025 | 2026 | 2025 | 2025 | |
| Net loss | (10,344) | (14,044) | (7,392) | (13,318) | (23,879) |
| Adjustments: | |||||
| Financing expenses, net | 7,110 | (3,060) | 2,099 | (7,564) | 1,556 |
| Other expenses, net | - | (4) | - | - | 13 |
| Taxes on income | (16) | (43) | (33) | (38) | (169) |
| Depreciation and amortization | (780) | (752) | (402) | (394) | (1,860) |
| Share-based compensation expenses | (1,399) | (1,706) | (755) | (862) | (3,108) |
| Total adjustments | 4,915 | (5,565) | 909 | (8,858) | (3,568) |
| Adjusted EBITDA | (15,259) | (8,479) | (8,301) | (4,460) | (20,311) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.